REAL-WORLD DURVALUMAB IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER

NCT06826677 · clinicaltrials.gov ↗

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Carcinoma

Interventions

DRUG: Durvalumab

Sponsor

AstraZeneca